Clinical Journal of Oncology Nursing - Nurse asks: must intraperitoneal paclitaxel be filtered?
June 1, 2008 -- I read the article "Intraperitoneal Chemotherapy for Women With Ovarian Cancer: Nursing Care and Considerations" (April 2008 issue of the...
Skin & Allergy News - Paclitaxel additive doubles survival in melanoma
November 1, 2006 -- NOORDWIJK, NETHERLANDS -- The addition of a novel small-molecule compound to paclitaxel in metastatic melanoma resulted in a doubling of...
HealthDay - Paclitaxel Plus Chemo Improves Outcomes in Early Breast Cancer
May 27, 2008 -- Adding paclitaxel to standard chemotherapy improved disease-free survival in women with early-stage breast cancer, a Spanish study finds. The phase...
Chemical Market Reporter - PACLITAXEL.
March 15, 1999 -- Ivax Corporation's s subsidiary, Baker Norton Pharmaceuticals, has received its first patent approval for its oral method of administering...
Skin & Allergy News - Paclitaxel formulation benefits malignant melanoma patients
February 1, 2007 -- NOORDWIJK, THE NETHERLANDS -- An albumin-bound formulation of paclitaxel approved for use in metastatic breast cancer also has demonstrated benefits...
PR Newswire - OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
September 2, 2008 -- BOTHELL, WA and VANCOUVER, Sept. 2 /PRNewswire-FirstCall/ -- OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") has...
Business Wire - Geron Initiates Clinical Trial of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Breast Cancer
August 7, 2008 -- Fifth Clinical Trial Program for GRN163L MENLO PARK, Calif. -- Geron Corporation (Nasdaq: GERN) today announced the enrollment of the first patient...
PR Newswire - Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN® and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
October 23, 2008 -- CALGARY, Oct. 23 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) today announced that an abstract entitled "Phase I...
PR Newswire - Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN® in Combination with Paclitaxel and Carboplatin
September 8, 2008 -- CALGARY, Sept. 8 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that that it has...
